We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Healthcare 7.7%
3 Consumer Discretionary 6.83%
4 Financials 6.52%
5 Industrials 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AORT icon
2101
Artivion
AORT
$1.37B
$70K ﹤0.01%
5,784
-336
-5% -$4.03K
LONA
2102
LeonaBio Inc
LONA
$69.5M
$70K ﹤0.01%
2,197
+398
+22% +$12.5K
DAVA icon
2103
Endava
DAVA
$154M
$70K ﹤0.01%
917
+437
+91% +$32.5K
GBX icon
2104
The Greenbrier Companies
GBX
$1.41B
$70K ﹤0.01%
2,091
-1,291
-38% -$43K
INBK icon
2105
First Internet Bancorp
INBK
$259M
$70K ﹤0.01%
2,863
+1,596
+126% +$42.2K
KNDI
2106
Kandi Technologies Group
KNDI
$63.3M
$70K ﹤0.01%
30,270
+21,815
+258% +$57.2K
NOMD icon
2107
Nomad Foods
NOMD
$1.6B
$70K ﹤0.01%
4,059
-612
-13% -$9.69K
NSIT icon
2108
Insight Enterprises
NSIT
$4.42B
$70K ﹤0.01%
701
-1,716
-71% -$164K
PCY icon
2109
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.39B
$70K ﹤0.01%
3,750
+3,638
+3,248% +$65.8K
SPRY icon
2110
ARS Pharmaceuticals
SPRY
$589M
$70K ﹤0.01%
8,162
+1,542
+23% +$10K
STLA icon
2111
Stellantis
STLA
$20.1B
$70K ﹤0.01%
4,922
-5,381
-52% -$74.9K
SUZ icon
2112
Suzano
SUZ
$9.8B
$70K ﹤0.01%
7,615
+6,730
+760% +$66.2K
TME icon
2113
Tencent Music
TME
$13.7B
$70K ﹤0.01%
8,486
+1,522
+22% +$8.55K
WAFD icon
2114
WaFd
WAFD
$2.78B
$70K ﹤0.01%
2,096
-7,571
-78% -$265K
PRSU
2115
Pursuit Attractions and Hospitality Inc
PRSU
$1.27B
$70K ﹤0.01%
2,899
-2,745
-49% -$85K
CDMO
2116
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$70K ﹤0.01%
5,105
+1,327
+35% +$20.3K
ACTG icon
2117
Acacia Research
ACTG
$451M
$69K ﹤0.01%
+16,401
New +$64.2K
OSG
2118
Octave Specialty Group
OSG
$206M
$69K ﹤0.01%
3,914
-2,172
-36% -$32.3K
AMR icon
2119
Alpha Metallurgical Resources
AMR
$1.96B
$69K ﹤0.01%
467
-451
-49% -$71.2K
ASTL icon
2120
Algoma Steel
ASTL
$473M
$69K ﹤0.01%
10,925
+10,222
+1,454% +$67.1K
BNO icon
2121
United States Brent Oil Fund
BNO
$788M
$69K ﹤0.01%
+2,450
New +$70.8K
KPTI icon
2122
Karyopharm Therapeutics
KPTI
$47.1M
$69K ﹤0.01%
1,341
-952
-42% -$66K
NG icon
2123
NovaGold Resources
NG
$3.53B
$69K ﹤0.01%
11,465
-15,061
-57% -$80.3K
PDFS icon
2124
PDF Solutions
PDFS
$2.15B
$69K ﹤0.01%
2,437
-2,597
-52% -$70.1K
RVLV icon
2125
Revolve Group
RVLV
$1.69B
$69K ﹤0.01%
3,086
-4,680
-60% -$112K

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.